Don't Punish the PBMs for Pharma's Pricing Problem

The latest misguided attack levied at PBMs comes from state attorneys general urging Congress to prohibit PBMs and their parent companies from owning pharmacies. Unfortunately, the State AGs are not only overlooking the safety of patients but fundamentally misunderstand the economics of the pharmaceutical supply chain, and doing such a thing would exacerbate the very problems it is supposed to fix.

 

Read Full Article »


Comment
Show comments Hide Comments


Related Articles

Market Overview
Search Stock Quotes